These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16284698)

  • 1. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate.
    Bodo J; Chovancova J; Hunakova L; Sedlak J
    Neoplasma; 2005; 52(6):510-6. PubMed ID: 16284698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin.
    Stehlik P; Paulikova H; Hunakova L
    Neoplasma; 2010; 57(5):473-81. PubMed ID: 20568902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations.
    Bodo J; Hunakova L; Kvasnicka P; Jakubikova J; Duraj J; Kasparkova J; Sedlak J
    Br J Cancer; 2006 Nov; 95(10):1348-53. PubMed ID: 17060935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells.
    Yunos NM; Beale P; Yu JQ; Huq F
    Anticancer Res; 2011 Apr; 31(4):1131-40. PubMed ID: 21508356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.
    Duraj J; Hunakova L; Bodo J; Jakubikova J; Chovancova J; Sedlak J
    Neoplasma; 2009; 56(3):208-14. PubMed ID: 19309223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic effect of ethyl-4-isothiocyanatobutanoate is associated with DNA damage, proteasomal activity and induction of p53 and p21cip1/waf1.
    Bodo J; Jakubikova J; Chalupa I; Bartosova Z; Horakova K; Floch L; Sedlak J
    Apoptosis; 2006 Aug; 11(8):1299-310. PubMed ID: 16830228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian cancer model.
    Qamar L; Davis R; Anwar A; Behbakht K
    Gynecol Oncol; 2008 Sep; 110(3):425-31. PubMed ID: 18619662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines.
    Alshehri A; Beale P; Yu JQ; Huq F
    Anticancer Res; 2010 Nov; 30(11):4547-53. PubMed ID: 21115904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells.
    Zhou L; Liu P; Chen B; Wang Y; Wang X; Chiriva Internati M; Wachtel MS; Frezza EE
    Anticancer Res; 2008; 28(2A):1119-27. PubMed ID: 18507063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of rapamycin and cisplatin in endometrial cancer cells.
    Bae-Jump VL; Zhou C; Boggess JF; Gehrig PA
    Cancer; 2009 Sep; 115(17):3887-96. PubMed ID: 19484784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A
    Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of that synergistic effect of cisplatin combined with compound herbal medicinal prescription for tonic quality and activating blood circulation is on SKOV3 cell proliferation and apoptosis].
    Suo YP; Wang BY; Hong Z; Yin RT; Wang DQ; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):542-6. PubMed ID: 16909597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models.
    Arzuman L; Beale P; Proschogo N; Yu JQ; Huq F
    Anticancer Res; 2015 Nov; 35(11):6027-39. PubMed ID: 26504026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines.
    Wan XA; Sun GP; Wang H; Xu SP; Wang ZG; Liu SH
    Dig Liver Dis; 2008 Jul; 40(7):531-9. PubMed ID: 18339596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T; Masuda H; Naito M; Tamai H
    Anticancer Res; 2001; 21(4A):2463-9. PubMed ID: 11724308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.
    Wahl H; Tan L; Griffith K; Choi M; Liu JR
    Gynecol Oncol; 2007 Apr; 105(1):104-12. PubMed ID: 17174384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-proliferative and pro-apoptotic effects from sequenced combinations of andrographolide and cisplatin on ovarian cancer cell lines.
    Yunos NM; Mutalip SS; Jauri MH; Yu JQ; Huq F
    Anticancer Res; 2013 Oct; 33(10):4365-71. PubMed ID: 24123004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction.
    Ercoli A; Battaglia A; Raspaglio G; Fattorossi A; Alimonti A; Petrucci F; Caroli S; Mancuso S; Scambia G
    Int J Cancer; 2000 Jan; 85(1):98-103. PubMed ID: 10585591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.